欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2018, Vol. 23 ›› Issue (2): 132-137.doi: 10.12092/j.issn.1009-2501.2018.02.003

• 基础研究 • 上一篇    下一篇

肾衰宁颗粒对糖尿病肾病大鼠肾组织NF-kB及PPAR-gamma表达的影响

姜莉莉,毛利民,胡思佳,彭应枝   

  1. 浙江医院药剂科,杭州 310013,浙江
  • 收稿日期:2017-07-19 修回日期:2017-10-22 出版日期:2018-02-26 发布日期:2018-03-02
  • 作者简介:姜莉莉,女,硕士,药师,研究方向:中药药理学。 Tel:13586282296 E-mail:j040365643@163.com
  • 基金资助:

    浙江省医药卫生科技计划项目(2013KYB002)

Effects of Shenshuaining granules on the expression of NF-kB and PPAR-gamma in kidney tissue of diabetic nephropathy rats

JIANG Lili, MAO Limin, HU Sijia, PENG Yingzhi   

  1. Department of Pharmacy, Zhejiang Hospital, Hangzhou 310013, Zhejiang, China
  • Received:2017-07-19 Revised:2017-10-22 Online:2018-02-26 Published:2018-03-02

摘要:

目的: 研究肾衰宁颗粒对糖尿病肾病大鼠肾组织核因子-κB(NF-κB)及过氧化物酶体增殖体激活受体γ(PPAR-γ)表达的影响。方法: 采用高脂饮食结合腹腔注射链脲佐菌素(35 mg/kg)法制备糖尿病SD大鼠模型,将40只大鼠随机分为对照组(等体积0.9% NaCl)、肾衰宁组(肾衰宁颗粒2 g/kg)、沙格列汀组(沙格列汀片0.6 mg/kg)和肾衰宁+沙格列汀组(肾衰宁颗粒2 g/kg+沙格列汀片0.6 mg/kg),灌胃给药1次/d,连续给药8周。HE染色评价肾脏病理变化,血糖仪检测空腹血糖(FBG),糖化血红蛋白仪检测糖化血红蛋白(HbA1c),全自动生化分析仪测定血清肌酸酐(Scr)、尿素氮(BUN)和血清胱抑素C(Cys-C),ELISA法检测血清肿瘤坏死因子-α(TNF-α)、细胞间黏附分子-1(ICAM-1)和单核细胞趋化因子-1(MCP-1)水平,免疫组化法检测肾小球NF-κB和PPAR-γ的表达。结果: 对照组肾小球毛细血管结构破坏,组织纤维化,毛细血管腔狭窄并有脂质沉积,肾间质血管增生,实验组肾小球病变改善,肾小球和毛细血管结构相对完整。实验组的FBG、HbA1c、Scr、BUN、Cys-C、TNF-α、ICAM-1、MCP-1显著低于对照组,差异均有统计学意义(P<0.05)。实验组的NF-κB表达显著低于对照组,而PPAR-γ表达高于对照组,差异均有统计学意义(P<0.05)。结论: 肾衰宁颗粒可改善糖尿病肾病大鼠肾脏肾小球和毛细血管结构,降低血糖,保护肾功能,减轻炎症反应,缓解肾脏病变,其机制可能与下调肾小球NF-κB表达和上调PPAR-γ表达有关。

关键词: 肾衰宁颗粒, 糖尿病肾病, 肾功能, 炎症反应, 核因子-κB, 过氧化物酶体增殖体激活受体γ

Abstract:

AIM: To study the effects of Shenshuaining granules on the expression of nuclear factor kappa B (NF-kB) and peroxisome proliferator activated receptor gamma (PPAR-gamma) in kidney tissue of diabetic nephropathy (DN) rats.  METHODS: The DN rats model were induced by high-fat diet combined with intraperitoneal injection of streptozotocin (35 mg/kg). Forty DN rats model were randomly divided into control group (same volume 0.9% NaCl), Shenshuaining (SSN) group (SSN granules 2 g/kg), saxagliptin group (saxagliptin tables 0.6 mg/kg), SSN and saxagliptin group (SSN granules 2 g/kg + saxagliptin tables 0.6 mg/kg) intragastric administration once per day, for 8 weeks. The renal pathological changes were evaluated by HE staining, the fasting blood glucose (FBG) were tested by glucose meter, glycosylated hemoglobin (HbA1c) were tested by glycated hemoglobin meter, serum creatinine (Scr), urea nitrogen (BUN) and serum Cystatin C (Cys-C) were tested by automatic biochemical analyzer, the levels of tumor necrosis factor alfa (TNF-alfa), intercellular adhesion factor-1 (ICAM-1) and monocyte chemotactic protein-1 (MCP-1) were detected by ELISA method, and the expression of NF-kB and PPAR-gamma were detected by immunohistochemical method. RESULTS:The glomerular capillary structure was damaged and fibrosis in the control group, and capillary lumen was shown stenosis and lipid deposition, the renal interstitial was also shown blood vessel growth. The glomerular lesions were improved in experimental group, and glomerular and capillary structures were relatively intact. The levels of FBG, HbA1c, Scr, BUN, Cys-C, TNF-alfa, ICAM-1 and MCP-1 in experimental group were significantly lower than those of control group, the differences had statistical significance (P<0.05). The expression of NF-kB in experimental group was significantly lower than that of the control group, and the expression of PPAR-gamma was higher than that of control group, the differences had statistical significance (P<0.05). CONCLUSION: Shenshuaining granules can improve the renal glomerulus and capillary structure for diabetic nephropathy rat, reduce blood sugar, protect renal function, alleviate inflammation, relieve kidney disease, the mechanism may be related with decreasing NF-kB expression and increasing PPAR-gamma expression in glomerular tissue.

Key words: Shenshuaining granules, diabetic nephropathy, renal function, inflammatory response, nuclear factor kappa B, peroxisome proliferator activated receptor gamma

中图分类号: